109 related articles for article (PubMed ID: 17486554)
1. NMR-guided fragment-based approach for the design of tRNA(Lys3) ligands.
Chung F; Tisné C; Lecourt T; Dardel F; Micouin L
Angew Chem Int Ed Engl; 2007; 46(24):4489-91. PubMed ID: 17486554
[No Abstract] [Full Text] [Related]
2. Design of tRNA(Lys)3 ligands: fragment evolution and linker selection guided by NMR spectroscopy.
Chung F; Tisné C; Lecourt T; Seijo B; Dardel F; Micouin L
Chemistry; 2009 Jul; 15(29):7109-16. PubMed ID: 19544516
[TBL] [Abstract][Full Text] [Related]
3. NMR-guided fragment-based approach for the design of AAC(6')-Ib ligands.
Lombès T; Bégis G; Maurice F; Turcaud S; Lecourt T; Dardel F; Micouin L
Chembiochem; 2008 Jun; 9(9):1368-71. PubMed ID: 18464231
[No Abstract] [Full Text] [Related]
4. Interactions of reverse transcriptase sequences in Pol with Gag and LysRS in the HIV-1 tRNALys3 packaging/annealing complex.
Saadatmand J; Guo F; Cen S; Niu M; Kleiman L
Virology; 2008 Oct; 380(1):109-17. PubMed ID: 18708237
[TBL] [Abstract][Full Text] [Related]
5. Using NMR for ligand discovery and optimization.
Villar HO; Yan J; Hansen MR
Curr Opin Chem Biol; 2004 Aug; 8(4):387-91. PubMed ID: 15288248
[TBL] [Abstract][Full Text] [Related]
6. Utilization of NMR-derived fragment leads in drug design.
Huth JR; Sun C; Sauer DR; Hajduk PJ
Methods Enzymol; 2005; 394():549-71. PubMed ID: 15808237
[TBL] [Abstract][Full Text] [Related]
7. SAR by ILOEs: an NMR-based approach to reverse chemical genetics.
Becattini B; Pellecchia M
Chemistry; 2006 Mar; 12(10):2658-62. PubMed ID: 16121405
[TBL] [Abstract][Full Text] [Related]
8. Fragment-based design of small RNA binders: promising developments and contribution of NMR.
Moumné R; Catala M; Larue V; Micouin L; Tisné C
Biochimie; 2012 Jul; 94(7):1607-19. PubMed ID: 22353243
[TBL] [Abstract][Full Text] [Related]
9. Solid-state NMR spectroscopy as a tool for drug design: from membrane-embedded targets to amyloid fibrils.
Middleton DA
Biochem Soc Trans; 2007 Nov; 35(Pt 5):985-90. PubMed ID: 17956260
[TBL] [Abstract][Full Text] [Related]
10. Design and implementation of an ribonucleic acid (RNA) directed fragment library.
Bodoor K; Boyapati V; Gopu V; Boisdore M; Allam K; Miller J; Treleaven WD; Weldeghiorghis T; Aboul-ela F
J Med Chem; 2009 Jun; 52(12):3753-61. PubMed ID: 19445516
[TBL] [Abstract][Full Text] [Related]
11. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
[TBL] [Abstract][Full Text] [Related]
12. [NMR-based approach for drug discovery].
Osawa M; Ikura M
Tanpakushitsu Kakusan Koso; 2002 Jun; 47(8 Suppl):948-54. PubMed ID: 12099045
[No Abstract] [Full Text] [Related]
13. A general approach for the identification of site-specific RNA binders by 19F NMR spectroscopy: proof of concept.
Kreutz C; Kählig H; Konrat R; Micura R
Angew Chem Int Ed Engl; 2006 May; 45(21):3450-3. PubMed ID: 16622887
[No Abstract] [Full Text] [Related]
14. Small molecule inhibitors targeting HIV-1 reverse transcriptase dimerization.
Grohmann D; Corradi V; Elbasyouny M; Baude A; Horenkamp F; Laufer SD; Manetti F; Botta M; Restle T
Chembiochem; 2008 Apr; 9(6):916-22. PubMed ID: 18318036
[TBL] [Abstract][Full Text] [Related]
15. Donor substrate binding to trans-sialidase of Trypanosoma cruzi as studied by STD NMR.
Blume A; Neubacher B; Thiem J; Peters T
Carbohydr Res; 2007 Sep; 342(12-13):1904-9. PubMed ID: 17597593
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine.
Wang Z; Vince R
Bioorg Med Chem; 2008 Apr; 16(7):3587-95. PubMed ID: 18314335
[TBL] [Abstract][Full Text] [Related]
17. [Discovering high-affinity ligands for proteins: SAR by NMR].
Kamisuki S; Uesugi M
Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1818-9. PubMed ID: 18051441
[No Abstract] [Full Text] [Related]
18. Crystallography-independent determination of ligand binding modes.
Orts J; Tuma J; Reese M; Grimm SK; Monecke P; Bartoschek S; Schiffer A; Wendt KU; Griesinger C; Carlomagno T
Angew Chem Int Ed Engl; 2008; 47(40):7736-40. PubMed ID: 18767090
[No Abstract] [Full Text] [Related]
19. Fragment shuffling: an automated workflow for three-dimensional fragment-based ligand design.
Nisius B; Rester U
J Chem Inf Model; 2009 May; 49(5):1211-22. PubMed ID: 19413347
[TBL] [Abstract][Full Text] [Related]
20. 19F NMR detection of the complex between amantadine and the receptor portion of the influenza A M2 ion channel in DPC micelles.
Kolocouris A; Zikos C; Broadhurst RW
Bioorg Med Chem Lett; 2007 Jul; 17(14):3947-52. PubMed ID: 17502147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
